Investors

Date	Name	Title	Type	Shares Traded	Price Range
Aug 20, 2008	roberts william	Officer	Disposition (Non Open Market)	10,582	21.40
Mar 21, 2011	mccorkle douglas s	Officer	Automatic Sell	10,600	40.02
Mar 21, 2011	mccorkle douglas s	Officer	Option Execute	10,600	20.32
Mar 29, 2008	vagelos p roy	Director	Disposition (Non Open Market)	10,669	n/a
Oct 5, 2009	vagelos p roy	Director	Disposition (Non Open Market)	10,796	n/a
Jul 26, 2011	powchik peter	Officer	Automatic Sell	10,977	54.74 - 55.19
Jan 10, 2012	terifay robert j	Officer	Automatic Sell	10,981	73.92
Jul 1, 2011	baker charles a	Director	Automatic Sell	11,000	55.94 - 57.40
Jul 1, 2011	baker charles a	Director	Option Execute	11,000	28.81
Dec 16, 2010	goldberg murray a	Officer	Automatic Sell	11,082	31.80
Dec 16, 2010	goldberg murray a	Officer	Automatic Sell	11,082	31.80
Nov 27, 2012	roberts william	Officer	Acquisition (Non Open Market)	11,500	n/a
Nov 27, 2012	roberts william	Officer	Disposition (Non Open Market)	11,500	n/a
Nov 30, 2012	roberts william	Officer	Sell	11,500	177.43 - 186.00
Mar 21, 2011	goldstein joseph l	Director	Automatic Sell	11,505	40.00
Nov 13, 2012	goldberg murray a	Officer	Automatic Sell	11,557	144.36 - 148.05
Oct 1, 2007	vagelos p roy	Director	Automatic Sell	11,560	n/a
Jan 6, 2009	vagelos p roy	Director	Disposition (Non Open Market)	11,771	n/a
Jul 6, 2009	vagelos p roy	Director	Disposition (Non Open Market)	11,837	n/a
Dec 13, 2011	gilman alfred g	Director	Disposition (Non Open Market)	11,875	n/a
Showing 341-360 of 638 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.